Special Report: Multi-Specialty Impact of COVID-19 (US)
Special Report: Multi-Specialty Impact of COVID-19 (US) is an ongoing series of monitoring evaluating the impact of COVID-19 on physicians and their practices – including, but not limited to, the utilization of telemedicine, at-risk patient groups, key concerns, support from industry, future changes in prescribing patterns, how practices are beginning to re-open, and what changes have been implemented as the new normal.
Specialty reports are available for dermatology, gastroenterology, nephrology, neurology, and rheumatology. Each wave will consist of feedback gathered from 250 specialists (~50 per specialty), geographically dispersed across the US. The report is offered by specialty and includes high-level cross-specialty comparisons trended since mid-March. Waves 8-10 are set to publish in July, August, and September.